Gelteq Ltd stock is traded at $0.4556, with a volume of 9,461. It is down -1.19% in the last 24 hours and down -16.20% over the past month. Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Previous Close:
$0.4611
Open:
$0.4608
24h Volume:
9,461
Relative Volume:
0.09
Market Cap:
$4.88M
Revenue:
$105.10K
Net Income/Loss:
-$4.30M
P/E Ratio:
-
EPS:
-$0.3691
Net Cash Flow:
-$3.91M
1W Performance:
-9.96%
1M Performance:
-16.20%
6M Performance:
-18.64%
1Y Performance:
-57.42%
1-Day Range:
$0.4301$0.4609
1-Week Range:
$0.4301$0.4969
52-Week Range:
$0.387$2.01
Gelteq Ltd Stock (GELS) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS